Drug target for inhibiting tumor, use, and oral drug

Abstract

The present disclosure relates to the technical field of targeted drug development, and in particular to a drug target for inhibiting a tumor and use thereof. Specifically, the present disclosure provides a drug target for inhibiting a tumor, where the drug target is a eukaryotic initiation factor 2 (EIF2). The present disclosure further provides use of the drug target for inhibiting a tumor and an oral drug. In the present disclosure, the drug target inhibits the initiation of translation in a eukaryotic cell by inhibiting translation of the EIF2, thereby safely suppressing a malignant phenotype of cancer cells.

Dependencies are inferred from the claim text.